Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Revenue (2016 - 2025)

INVO Fertility (IVF) has disclosed Revenue for 15 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Revenue rose 22.6% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.9 million, a 11.5% increase, with the full-year FY2024 number at $6.5 million, up 116.25% from a year prior.
  • Revenue was $1.8 million for Q3 2025 at INVO Fertility, down from $1.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.0 million in Q4 2021 to a low of $146135.0 in Q2 2022.
  • A 5-year average of $1.0 million and a median of $974894.0 in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 1450.7% in 2021, then plummeted 90.88% in 2022.
  • INVO Fertility's Revenue stood at $3.0 million in 2021, then tumbled by 90.88% to $278142.0 in 2022, then skyrocketed by 396.78% to $1.4 million in 2023, then rose by 22.02% to $1.7 million in 2024, then grew by 4.22% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Revenue are $1.8 million (Q3 2025), $1.9 million (Q2 2025), and $1.6 million (Q1 2025).